Veronika Reiterer
Overview
Explore the profile of Veronika Reiterer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zahoor M, Dong Y, Preussner M, Reiterer V, Shameen Alam S, Haun M, et al.
EMBO J
. 2024 Aug;
43(19):4228-4247.
PMID: 39160274
Splicing and endoplasmic reticulum (ER)-proteostasis are two key processes that ultimately regulate the functional proteins that are produced by a cell. However, the extent to which these processes interact remains...
2.
Heimdorfer D, Vorleuter A, Eschlbock A, Spathopoulou A, Suarez-Cubero M, Farhan H, et al.
Am J Hum Genet
. 2024 Jun;
111(7):1383-1404.
PMID: 38908375
The neurodevelopmental disorders Prader-Willi syndrome (PWS) and Schaaf-Yang syndrome (SYS) both arise from genomic alterations within human chromosome 15q11-q13. A deletion of the SNORD116 cluster, encoding small nucleolar RNAs, or...
3.
Ghannoum S, Fantini D, Zahoor M, Reiterer V, Phuyal S, Leoncio Netto W, et al.
PLoS Comput Biol
. 2023 Apr;
19(4):e1010995.
PMID: 37068117
Our understanding of how speed and persistence of cell migration affects the growth rate and size of tumors remains incomplete. To address this, we developed a mathematical model wherein cells...
4.
El-Gazzar A, Voraberger B, Rauch F, Mairhofer M, Schmidt K, Guillemyn B, et al.
EMBO Mol Med
. 2023 Mar;
15(4):e16834.
PMID: 36916446
Osteogenesis imperfecta (OI) is a genetically and clinically heterogeneous disorder characterized by bone fragility and reduced bone mass generally caused by defects in type I collagen structure or defects in...
5.
Phuyal S, Djaerff E, Le Roux A, Baker M, Fankhauser D, Mahdizadeh S, et al.
EMBO J
. 2022 Aug;
41(18):e110596.
PMID: 35938214
Cells are constantly exposed to various chemical and physical stimuli. While much has been learned about the biochemical factors that regulate secretory trafficking from the endoplasmic reticulum (ER), much less...
6.
Barnault R, Verzeroli C, Fournier C, Michelet M, Redavid A, Chicherova I, et al.
Hepatology
. 2022 Mar;
76(5):1345-1359.
PMID: 35253915
Background And Aims: Netrin-1 displays protumoral properties, though the pathological contexts and processes involved in its induction remain understudied. The liver is a major model of inflammation-associated cancer development, leading...
7.
Riguet N, Mahul-Mellier A, Maharjan N, Burtscher J, Croisier M, Knott G, et al.
Nat Commun
. 2021 Nov;
12(1):6579.
PMID: 34772920
Despite the strong evidence linking the aggregation of the Huntingtin protein (Htt) to the pathogenesis of Huntington's disease (HD), the mechanisms underlying Htt aggregation and neurodegeneration remain poorly understood. Herein,...
8.
Reiterer V, Pawlowski K, Desrochers G, Pause A, Sharpe H, Farhan H
FEBS J
. 2020 Jun;
287(19):4198-4220.
PMID: 32484316
Phosphatases are a diverse family of enzymes, comprising at least 10 distinct protein folds. Like most other enzyme families, many have sequence variations that predict an impairment or loss of...
9.
Centonze F, Reiterer V, Nalbach K, Saito K, Pawlowski K, Behrends C, et al.
J Cell Biol
. 2019 Jun;
218(8):2470-2480.
PMID: 31227593
The endoplasmic reticulum (ER) is a key regulator of cellular proteostasis because it controls folding, sorting, and degradation of secretory proteins. Much has been learned about how environmentally triggered signaling...
10.
Reiterer V, Figueras-Puig C, Le Guerroue F, Confalonieri S, Vecchi M, Jalapothu D, et al.
EMBO J
. 2018 Mar;
37(6).
PMID: 29545456
No abstract available.